Ultrasound Therapy

There is a new therapy of implanting an ultrasound device, called SonoCloud-9, to treat patients with glioblastoma that has recurred. SonoCloud® uses the therapeutic potential of pulsed ultrasound to temporarily disrupt the blood-brain barrier (BBB). With the BBB disrupted this opens a window where drug therapies can be administered. The goal is for drugs to reach the brain in higher and more effective concentrations during this time.

Read more on SonoCloud® Technology at Carthera’s website here.

Read about a study on SonoCloud® Technology here at the National Cancer Institute.